Skip to main content
ARS Pharmaceuticals, Inc. logo

ARS Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · SPRY ISIN · US82835W1080 US Manufacturing
Filings indexed 491 across all filing types
Latest filing 2021-02-08 Major Shareholding Noti…
Country US United States of America
Listing US SPRY

About ARS Pharmaceuticals, Inc.

https://ars-pharma.com/

ARS Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative, needle-free products for administering therapies. The company's lead product is neffy (epinephrine nasal spray), the first and only FDA-approved needle-free treatment for severe allergic reactions (Type I hypersensitivity), including anaphylaxis. Developed as a patient-friendly alternative to auto-injectors, neffy is designed to be easy to carry and use, addressing challenges such as needle-related risks and hesitation in administration for both patients and caregivers.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2021
Major Shareholding Notification
2021-02-08 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-01-04 English
SC 13G/A
Major Shareholding Notification
2020-12-18 English
SC 13G
Major Shareholding Notification
2020-12-17 English
SC 13D
Major Shareholding Notification
2020-12-14 English
SCHEDULE 13D
Major Shareholding Notification
2020-12-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.